Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications-Reference-Cited by-同舟云学术

Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications

Published:2017 Issue:3 Volume:6 Page:204-215
ISSN:2235-1795
Container-title:Liver Cancer
language:en
Short-container-title:Liver Cancer

Author:

Hiraoka Atsushi,Kumada Takashi,Kudo Masatoshi,Hirooka Masashi,Tsuji Kunihiko,Itobayashi Ei,Kariyama Kazuya,Ishikawa Toru,Tajiri Kazuto,Ochi Hironori,Tada Toshifumi,Toyoda Hidenori,Nouso Kazuhiro,Joko Kouji,Kawasaki Hideki,Hiasa Yoichi,Michitaka Kojiro,

Publisher

S. Karger AG

Subject

Oncology,Hepatology

Reference30 articles.

1. Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)

2. Predictors of peri-opertative morbidity and liver dysfunction after hepatic resection in patients with chronic liver disease

3. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy

4. Surgery for small liver cancers

5. Transection of the oesophagus for bleeding oesophageal varices

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Camrelizumab, apatinib and hepatic artery infusion chemotherapy combined with microwave ablation for advanced hepatocellular carcinoma;World Journal of Gastrointestinal Oncology;2024-08-15

2. Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab;JCO Clinical Cancer Informatics;2024-08

3. Subsequent locoregional therapy prolongs survival in progressive hepatocellular carcinoma patients under lenvatinib treatment;Journal of the Formosan Medical Association;2024-07

4. DEB‐TACE versus cTACE for unresectable HCC with B1‐type bile duct invasion after successful biliary drainage: A propensity score matching analysis;Cancer Medicine;2024-07

5. Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study;Liver Cancer;2024-06-14